MyMeds&Me appoints Caroline O’Connor as Chief Commercial Officer

MyMeds&Me appoints Caroline O’Connor as Chief Commercial Officer


MyMeds&Me, a leading provider of global pharmacovigilance solutions, has today announced the appointment of Caroline O’Connor as Chief Commercial Officer.

Caroline has a wealth of experience in commercial roles across life sciences technology and services, with a proven track record in expanding global reach in fast-growing businesses. Over the past decade her focus has been on data capture and patient-support technology businesses, achieving significant revenue growth both pre- and post-approval through eClinical, RWE, and Digital Patient Support Programs.

As MyMeds&Me Chief Commercial Officer, Caroline will be instrumental in transforming the commercial strategy and driving business growth following the acquisition by Stanley Capital.

“I’m very pleased to welcome Caroline as our new CCO at such a pivotal time” commented Dr Andrew Rut, CEO and founder of MyMeds&Me. “Caroline has a very strong background in establishing value and driving revenue in fast-growing organisations. Her exceptional experience and knowledge will play a vital role as we shape the strategic direction of the combined organisation while delivering great products to customers.”

The appointment follows the acquisition of MyMeds&Me by Stanley Capital Partners LLP to form an integral part of its portfolio company Drug Safety and Pharmacovigilance Services Solutions (DSS).

Read more here

Request More Information

To find out more or request a demo fill in the details below:

By submitting your information, you are consenting to receive communications from MyMeds&Me. You may at any time 'opt out' of receiving these marketing communications by emailing


We use analytical cookies that need your permission. For more details and advanced options view our Cookies Policy.